We are excited to announce the launch of our preclinical ECG analytics services as a new extension of our electrophysiology solutions.

This capability provides cardiac safety and physiology, fully integrated with our platformed neurophysiology analytics.

All analyses are performed under GLP compliance, ensuring the highest standards of data integrity, traceability, and audit readiness for regulatory submissions.

With this offering, we now also support telemetry collections from implanted large animals, aligned with ICH S7A regulatory guidance.

This addition empowers pharmaceutical and biotech partners to address critical cardiovascular safety endpoints with confidence. By uniting ECG and CNS analytics in a single GLP-validated platform, we deliver a comprehensive translational solution from discovery through regulatory approval.